591 related articles for article (PubMed ID: 10627494)
1. Potential role of phospholipases in virulence and fungal pathogenesis.
Ghannoum MA
Clin Microbiol Rev; 2000 Jan; 13(1):122-43, table of contents. PubMed ID: 10627494
[TBL] [Abstract][Full Text] [Related]
2. Extracellular phospholipases as universal virulence factor in pathogenic fungi.
Ghannoum MA
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):55-9. PubMed ID: 9580028
[TBL] [Abstract][Full Text] [Related]
3. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans.
Leidich SD; Ibrahim AS; Fu Y; Koul A; Jessup C; Vitullo J; Fonzi W; Mirbod F; Nakashima S; Nozawa Y; Ghannoum MA
J Biol Chem; 1998 Oct; 273(40):26078-86. PubMed ID: 9748287
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans.
Sugiyama Y; Nakashima S; Mirbod F; Kanoh H; Kitajima Y; Ghannoum MA; Nozawa Y
Med Mycol; 1999 Feb; 37(1):61-7. PubMed ID: 10200936
[TBL] [Abstract][Full Text] [Related]
5. Silkworm as an experimental animal for research on fungal infections.
Matsumoto Y; Sekimizu K
Microbiol Immunol; 2019 Feb; 63(2):41-50. PubMed ID: 30666711
[TBL] [Abstract][Full Text] [Related]
6. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
Karkowska-Kuleta J; Rapala-Kozik M; Kozik A
Acta Biochim Pol; 2009; 56(2):211-24. PubMed ID: 19543556
[TBL] [Abstract][Full Text] [Related]
7. Lipolytic enzymes involved in the virulence of human pathogenic fungi.
Park M; Do E; Jung WH
Mycobiology; 2013 Jun; 41(2):67-72. PubMed ID: 23874127
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans.
Fu Y; Ibrahim AS; Fonzi W; Zhou X; Ramos CF; Ghannoum MA
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():331-340. PubMed ID: 9043110
[TBL] [Abstract][Full Text] [Related]
9. Human fungal pathogens: Why should we learn?
Kim JY
J Microbiol; 2016 Mar; 54(3):145-8. PubMed ID: 26920875
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?
Swenson CE; Perkins WR; Roberts P; Ahmad I; Stevens R; Stevens DA; Janoff AS
Antimicrob Agents Chemother; 1998 Apr; 42(4):767-71. PubMed ID: 9559780
[TBL] [Abstract][Full Text] [Related]
11. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.
Cox GM; McDade HC; Chen SC; Tucker SC; Gottfredsson M; Wright LC; Sorrell TC; Leidich SD; Casadevall A; Ghannoum MA; Perfect JR
Mol Microbiol; 2001 Jan; 39(1):166-75. PubMed ID: 11123698
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase activity in Cryptococcus neoformans.
Vidotto V; Sinicco A; Di Fraia D; Cardaropoli S; Aoki S; Ito-Kuwa S
Mycopathologia; 1996-1997; 136(3):119-23. PubMed ID: 9276940
[TBL] [Abstract][Full Text] [Related]
13. Evidence implicating phospholipase as a virulence factor of Candida albicans.
Ibrahim AS; Mirbod F; Filler SG; Banno Y; Cole GT; Kitajima Y; Edwards JE; Nozawa Y; Ghannoum MA
Infect Immun; 1995 May; 63(5):1993-8. PubMed ID: 7729913
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of fungal dissemination.
Strickland AB; Shi M
Cell Mol Life Sci; 2021 Apr; 78(7):3219-3238. PubMed ID: 33449153
[TBL] [Abstract][Full Text] [Related]
15. Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo.
Mukherjee PK; Seshan KR; Leidich SD; Chandra J; Cole GT; Ghannoum MA
Microbiology (Reading); 2001 Sep; 147(Pt 9):2585-2597. PubMed ID: 11535799
[TBL] [Abstract][Full Text] [Related]
16. Disarming Fungal Pathogens:
Mayer FL; Kronstad JW
mBio; 2017 Oct; 8(5):. PubMed ID: 28974618
[TBL] [Abstract][Full Text] [Related]
17. [Are there pathogenicity factors in fungi?].
Morschhäuser J; Köhler G; Hacker J
Mycoses; 1996; 39 Suppl 1():51-4. PubMed ID: 8767271
[TBL] [Abstract][Full Text] [Related]
18. Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis.
Ramos Lde S; Barbedo LS; Braga-Silva LA; dos Santos AL; Pinto MR; Sgarbi DB
Rev Iberoam Micol; 2015; 32(2):122-5. PubMed ID: 24853474
[TBL] [Abstract][Full Text] [Related]
19. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
20. Virulence properties and nonimmune pathogenetic mechanisms of fungi.
Vartivarian SE
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S30-6. PubMed ID: 1562692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
